IFNG and adrenal cortex adenoma: The results showed that 34.3% of the adrenal cortical adenomas, 50% of the adrenal cortical carcinomas, 26.7% of the phaeochromocytomas and 26.7% of the clear cell RCC expressed IFN-γ immunoactivity.